Volicure Trio 3/0.3/500 mg Tablet (15 Tab)

About Volicure Trio 3/0.3/500 mg Tablet:

Volicure Trio 3/0.3/500 mg Tablet is a combination of three antidiabetic medications, used to treat type 2 diabetes mellitus. It helps to control high blood glucose levels.

Each uncoated bilayered Volicure Trio 3/0.3/500 mg Tablet contains Glimepiride 3 mg and Voglibose 0.3 mg and Metformin Hydrochloride 500 mg (as sustained-release form).

Metformin is a biguanide antihyperglycaemic agent which improves glucose tolerance by lowering both basal and postprandial plasma glucose. It decreases hepatic glucose production, delays intestinal glucose absorption, and improves insulin sensitivity by enhancing peripheral glucose uptake and utilization.

Glimepiride, an antidiabeticsulphonylurea, reduces blood glucose by stimulating the insulin release from pancreatic ß-cells and decreases glucose output from the liver. It also increases insulin sensitivity at peripheral target sites.

Voglibose is an alpha-glucosidase inhibitor used for lowering post-prandial blood glucose levels in people with type 2 diabetes mellitus.

Hence, the combination of Glimepiride, Metformin, and Voglibose complements each other and provides better glycemic control in the management of type 2 diabetes and probably in the prevention of its associated macrovascular and microvascular complications.

Use of Volicure Trio 3/0.3/500 mg Tablet:

Volicure Trio 3/0.3/500 mg Tablet is prescribed for the treatment of patients with type 2 diabetes mellitus.

Usage Direction of Volicure Trio 3/0.3/500 mg Tablet:

• Volicure Trio 3/0.3/500 mg Tablet is intended for oral use only, in a dose and direction as prescribed by the physician.
• Volicure Trio 3/0.3/500 mg Tablet should be swallowed whole.
• Do not crush or chew the tablet.
• Do not skip or stop the medicine without the physician’s advice.
• Do not exceed the stated recommended daily dosage.

Precaution & Related information of Volicure Trio 3/0.3/500 mg Tablet:

• Warning: It is dangerous to take this preparation except under medical supervision.
• Inform the physician immediately, if the patient is hypersensitive to Volicure Trio 3/0.3/500 mg Tablet.
• Inform the physician immediately, if the patient is having any other complications.
• The physician should be aware of the concomitant use of Volicure Trio 3/0.3/500 mg Tablet with any other medication.
• Consult with the physician during pregnancy & lactation.
• Keep all medicines out of reach of children.

Storage condition of Volicure Trio 3/0.3/500 mg Tablet:

Store protected from light & moisture, at a temperature not exceeding 30°C.